# Lipid Regulation of Mechanosensitive Ion Channels

**Authors:** Yurou Cai, Claudia Bauer, Jian Shi

PMC · DOI: 10.3390/ijms27041984 · International Journal of Molecular Sciences · 2026-02-19

## TL;DR

This paper reviews how lipids regulate mechanosensitive ion channels, which are crucial for converting mechanical forces into cellular signals and are involved in various diseases.

## Contribution

The paper synthesizes current knowledge on lipid modulation of mechanosensitive ion channels, highlighting new therapeutic opportunities.

## Key findings

- Endogenous lipids like cholesterol and phospholipids modulate mechanosensitive ion channels by altering membrane properties.
- Exogenous lipids influence these channels by modifying membrane physical properties or interacting with channel proteins.
- Lipid regulation of mechanosensitive ion channels is linked to diseases like cardiovascular dysfunction and cancer.

## Abstract

Mechanosensitive ion channels (MSCs) are fundamental transducers that convert mechanical forces into electrochemical signals, enabling cells to regulate processes such as Ca2+ homeostasis, migration, proliferation, and adhesion. Located in both plasma and organellar membranes, MSCs, including Piezos, TRPs, K2Ps, MscL, and MscS families exhibit diverse ion selectivity, gating mechanisms and physiological roles. Emerging evidence demonstrates that lipids are dynamic regulators of MSC activation, sensitivity, and kinetics. Endogenous membrane lipids such as cholesterol, phospholipids, sphingolipids and fatty acids modulate MSC behavior by altering bilayer tension, curvature, stiffness and protein–lipid interactions. Exogenous lipids, including dietary fatty acids and lipid-derived metabolites, influence MSCs by modifying membrane physical properties or engaging specific lipid-binding sites on channel proteins. These interactions shape fundamental biological processes and contribute to disease mechanisms in cardiovascular dysfunction, neurological disorders, metabolic disease, and cancer. Despite significant progress, the molecular principles by which lipids regulate MSC conformational transitions and force sensing remain incompletely defined. This review synthesizes current knowledge on endogenous and exogenous lipid modulation of MSCs, integrating structural, computational and electrophysiological insights to highlight emerging therapeutic opportunities targeting lipid–mechanotransduction interfaces.

## Linked entities

- **Proteins:** trpS (tryptophan--tRNA ligase), mscL (large-conductance mechanosensitive channel), mscS (mechanosensitive channel protein)
- **Chemicals:** cholesterol (PubChem CID 5997), fatty acids (PubChem CID 264)
- **Diseases:** metabolic disease (MONDO:0005066), cancer (MONDO:0004992)

## Full-text entities

- **Genes:** cav1.L (caveolin 1 L homeolog) [NCBI Gene 398392] {aka Cav-1, bscl3, cav1, cav1-a, cav1-b, cav1.S}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, INF2 (inverted formin 2) [NCBI Gene 64423] {aka C14orf151, C14orf173, CMTDIE, FSGS5, pp9484}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, Trpc5 (transient receptor potential cation channel, subfamily C, member 5) [NCBI Gene 22067] {aka CCE2, TRP-5, TRP5, Trrp5}, PIEZO2 (piezo type mechanosensitive ion channel component 2) [NCBI Gene 63895] {aka C18orf30, C18orf58, DA3, DA5, DAIPT, FAM38B}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, KCNK10 (potassium two pore domain channel subfamily K member 10) [NCBI Gene 54207] {aka K2p10.1, PPP1R97, TREK-2, TREK2}, TMC1 (transmembrane channel like 1) [NCBI Gene 117531] {aka DFNA36, DFNB11, DFNB7}, Kcnk4 (potassium channel, subfamily K, member 4) [NCBI Gene 16528] {aka TRAAK, TRAAKt}, TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341] {aka BCYM3, CMT2C, HMSN2C, OTRPC4, SMAL, SPSMA}, TRPC3 (transient receptor potential cation channel subfamily C member 3) [NCBI Gene 7222] {aka SCA41, TRP3}, Trpc6 (transient receptor potential cation channel, subfamily C, member 6) [NCBI Gene 22068] {aka LLHWJM002, LLHWJM003, LLHWJM004, TRP-6, Trrp6, mtrp6}, KCNK2 (potassium two pore domain channel subfamily K member 2) [NCBI Gene 3776] {aka K2p2.1, TPKC1, TREK, TREK-1, TREK1, hTREK-1c}, Kcnk10 (potassium channel, subfamily K, member 10) [NCBI Gene 72258] {aka 1700024D23Rik, 3010005K24Rik, Trek2}, Piezo1 (piezo-type mechanosensitive ion channel component 1) [NCBI Gene 234839] {aka 9630020g22, Fam38a, mKIAA0233}, ASIC3 (acid sensing ion channel subunit 3) [NCBI Gene 9311] {aka ACCN3, DRASIC, SLNAC1, TNaC1}, SMPD4 (sphingomyelin phosphodiesterase 4) [NCBI Gene 55627] {aka NEDMABA, NEDMEBA, NET13, NSMASE-3, NSMASE3, SKNY}, TMEM63C (transmembrane protein 63C) [NCBI Gene 57156] {aka C14orf171, CSC1, SPG87, hTMEM63C, hsCSC1}, ASIC2 (acid sensing ion channel subunit 2) [NCBI Gene 40] {aka ACCN, ACCN1, ASIC2a, BNC1, BNaC1, MDEG}, LHFPL5 (LHFPL tetraspan subfamily member 5) [NCBI Gene 222662] {aka DFNB67, TMHS, dJ510O8.8}, ATP11A (ATPase phospholipid transporting 11A) [NCBI Gene 23250] {aka ATPIH, ATPIS, AUNA2, DFNA84, HLD24}, Stoml1 (stomatin-like 1) [NCBI Gene 69106] {aka 1810015E19Rik, SLP1, STORP, UNC24, WPB72}, CIB3 (calcium and integrin binding family member 3) [NCBI Gene 117286] {aka KIP3}, TRPC6 (transient receptor potential cation channel subfamily C member 6) [NCBI Gene 7225] {aka FSGS2, TRP6}, IL36G (interleukin 36 gamma) [NCBI Gene 56300] {aka IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1}, ASIC1 (acid sensing ion channel subunit 1) [NCBI Gene 41] {aka ACCN2, ASIC, BNaC2}, TMC2 (transmembrane channel like 2) [NCBI Gene 117532] {aka C20orf145}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, GPLD1 (glycosylphosphatidylinositol specific phospholipase D1) [NCBI Gene 2822] {aka GPIPLD, GPIPLDM, PIGPLD, PIGPLD1, PLD}, Hmgcr (3-hydroxy-3-methylglutaryl-Coenzyme A reductase) [NCBI Gene 15357] {aka HMG-CoAR, Red}, SMPD2 (sphingomyelin phosphodiesterase 2) [NCBI Gene 6610] {aka ISC1, NSMASE, NSMASE1}, TMEM63B (transmembrane protein 63B) [NCBI Gene 55362] {aka C6orf110, DEE118, hTMEM63B}, TMEM120A (transmembrane protein 120A) [NCBI Gene 83862] {aka NET29, TACAN, TMPIT}, SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}, SREBF1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 6720] {aka HMD, IFAP2, SREBP1, bHLHd1}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, CIB2 (calcium and integrin binding family member 2) [NCBI Gene 10518] {aka DFNB48, KIP2, USH1J}, TMEM63A (transmembrane protein 63A) [NCBI Gene 9725] {aka HLD19, KIAA0792, hTMEM63A}, KRT76 (keratin 76) [NCBI Gene 51350] {aka HUMCYT2A, KRT2B, KRT2P}, Piezo2 (piezo-type mechanosensitive ion channel component 2) [NCBI Gene 667742] {aka 5930434P17, 9030411M15Rik, 9430028L06Rik, Fam38b, Fam38b2}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 7442] {aka VR1}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, Asic2 (acid-sensing ion channel 2) [NCBI Gene 11418] {aka ACIC2, Accn1, BNC1, BNaC1, BNaC1a, Mdeg}, PCDH15 (protocadherin related 15) [NCBI Gene 65217] {aka CDHR15, DFNB23, USH1F}, NPHS2 (NPHS2 stomatin family member, podocin) [NCBI Gene 7827] {aka PDCN, SRN1}, Kcnk2 (potassium channel, subfamily K, member 2) [NCBI Gene 16526] {aka A430027H14Rik, K2P2.1, TREK-1}, HSPG2 (heparan sulfate proteoglycan 2) [NCBI Gene 3339] {aka HSPG, PLC, PRCAN, SJA, SJS, SJS1}, Stoml3 (stomatin (Epb7.2)-like 3) [NCBI Gene 229277] {aka Epb7.2l, SLP3, sro}, TRPV2 (transient receptor potential cation channel subfamily V member 2) [NCBI Gene 51393] {aka VRL, VRL-1, VRL1}, PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}, Cav1 (caveolin 1) [NCBI Gene 25404] {aka Cav}, nompC (no mechanoreceptor potential C) [NCBI Gene 33768] {aka CG11020, CG17468, CT30855, DmNompC, Dmel\CG11020, ORE-13}, TPSG1 (tryptase gamma 1) [NCBI Gene 25823] {aka PRSS31, TMT, trpA}, TRPC1 (transient receptor potential cation channel subfamily C member 1) [NCBI Gene 7220] {aka HTRP-1, TRP1}, ANO6 (anoctamin 6) [NCBI Gene 196527] {aka BDPLT7, SCTS, TMEM16F}, TRPA1 (transient receptor potential cation channel subfamily A member 1) [NCBI Gene 8989] {aka ANKTM1, FEPS, FEPS1, p120}
- **Diseases:** nonsyndromic deafness (MESH:C580334), pulmonary hypertension (MESH:D006976), hemolysis (MESH:D006461), cartilage degeneration (MESH:D002357), Charcot-Marie-Tooth-like syndromes (MESH:D002607), CH (MESH:D000860), prostate tumor (MESH:D011472), DEE (MESH:C562695), corpus callosum abnormalities (MESH:D061085), migraine (MESH:D008881), bladder hypoactivity (MESH:D001745), ADPKD (MESH:D016891), hypoxic-ischemic brain disorders (MESH:D020925), lipid (MESH:D011017), developmental delay (MESH:D002658), ischemia (MESH:D007511), hereditary motor and sensory neuropathies (MESH:D015417), Neurological Disorders (MESH:D009461), osteoarthritis (MESH:D010003), metabolic disease (MESH:D008659), multiple sclerosis (MESH:D009103), Merkel cell carcinoma (MESH:D015266), SCA (MESH:D000755), stroke (MESH:D020521), Liver Disorders (MESH:D017093), hypersensitivity (MESH:D004342), ovarian cancer (MESH:D010051), hepatic damage (MESH:D056486), glaucoma (MESH:D005901), Niemann-Pick disease (MESH:D009542), FSGS (MESH:D005923), depression (MESH:D003866), neurological disease (MESH:D020271), chronic pain (MESH:D059350), splenomegaly (MESH:D013163), facial dysmorphism (MESH:C565579), musculoskeletal dysfunction (MESH:D009140), white matter disease (MESH:D056784), hypertrichosis (MESH:D006983), skeletal dysplasias (MESH:C535858), channelopathies (MESH:D053447), neuroinflammation (MESH:D000090862), lymphatic dysplasia (MESH:C537255), macular degeneration (MESH:D008268), hereditary anemia (MESH:D000745), cholestasis (MESH:D002779), vascular disease (MESH:D014652), ischemic (MESH:D002545), Huntington's disease (MESH:D006816), diabetic retinopathy (MESH:D003930), Cancer (MESH:D009369), gingival overgrowth (MESH:D019214), AD (MESH:D000544), deafness (MESH:D003638), neurological and psychiatric disorders (MESH:D001523), vascular dilation (MESH:D002311), Cardiovascular Disease (MESH:D002318), HX (MESH:C566369), Parkinson's disease (MESH:D010300), mitochondrial and (MESH:D028361)
- **Chemicals:** latrunculin A (MESH:C037067), benzbromarone (MESH:D001553), calcium (MESH:D002118), ceramide (MESH:D002518), LPA (MESH:C032881), phosphocholine (MESH:D010767), ketone bodies (MESH:D007657), stigmasterol (MESH:D013265), NO (MESH:D009569), Cholesterol (MESH:D002784), inositol (MESH:D007294), oxysterols (MESH:D000072376), alcohol (MESH:D000438), DAG (MESH:D004075), fura-2 (MESH:D016257), beeswax (MESH:C038228), glycolipids (MESH:D006017), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (MESH:C020888), colchicine (MESH:D003078), Sphingolipid (MESH:D013107), LPC (MESH:D008244), acetylcholine (MESH:D000109), Fluvastatin (MESH:D000077340), MA (MESH:C013102), PG (MESH:D010715), sterol (MESH:D013261), azolectin (MESH:C024990), DHA (MESH:D004281), LPS (MESH:D008070), AA (MESH:D016718), Lipid (MESH:D008055), CL (MESH:D002308), mannitol (MESH:D008353), LysoPS (MESH:C025059), steroids (MESH:D013256), phosphoserine (MESH:D010768), IP3 (MESH:D015544), ATP (MESH:D000255), Phospholipids (MESH:D010743), EPA (MESH:D015118), 1,2-dioleoyl-sn-glycero-3-phosphocholine (MESH:C017251), PC (MESH:C053518), PS (MESH:D010718), CA (MESH:D019826), phosphatidylcholine (MESH:D010713), Fatty Acids (MESH:D005227), esters (MESH:D004952), 17,18-epoxyeicosatetraenoic acid (MESH:C070378), aldosterone (MESH:D000450), waxes (MESH:D014885), PA (MESH:D010712), cortisol (MESH:D006854), glycosphingolipid (MESH:D006028), MbetaCD (MESH:C108732), PIP2 (MESH:D019269), bilirubin (MESH:D001663), lysophospholipids (MESH:D008246), Na+ (MESH:D012964), oxygen (MESH:D010100), PUFA (MESH:D005231)
- **Species:** Drosophila melanogaster (fruit fly, species) [taxon 7227], Diptera (flies, order) [taxon 7147], C. elegans [taxon 328850], Gallus gallus (bantam, species) [taxon 9031], Xenopus laevis (African clawed frog, species) [taxon 8355], Homo sapiens (human, species) [taxon 9606], Mycobacterium tuberculosis (species) [taxon 1773], Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Rattus norvegicus (brown rat, species) [taxon 10116], Danio rerio (leopard danio, species) [taxon 7955], Escherichia coli (E. coli, species) [taxon 562], Arabidopsis thaliana (mouse-ear cress, species) [taxon 3702]
- **Mutations:** R616Q, E756del
- **Cell lines:** HEK — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_M624), HMVEC — Homo sapiens (Human), Transformed cell line (CVCL_0307), N2A — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470), HX — Homo sapiens (Human), Hereditary angioedema, Transformed cell line (CVCL_WA80)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940486/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940486/full.md

## References

296 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940486/full.md

---
Source: https://tomesphere.com/paper/PMC12940486